Skip to Content

Rentokil Earnings: Dampened Economic Outlook Offers Minimal Challenge in Early 2023

""
Securities In This Article
Rentokil Initial PLC
(RTO)

Wide-moat Rentokil Initial’s RTO 2023 interim result was robust, with its performance in the first six months of 2023 largely unhindered by expectations for softening economic conditions in its two largest markets—the U.S. and Europe. Still, organic growth softened slightly in the second quarter to 5.9%, down from a heightened 6.7% in the first three months of the year, aligning with our expectations for a modest slowing in organic pest control and hygiene volumes as 2023 progresses. Our 2023 estimates remain largely unchanged—we forecast full-year EBIT of GBP 935 million and EPS of GBP 0.24—as do our long-term expectations for the wide-moat stock. Nonetheless, a time value of money adjustment leads us to lift our fair value estimate by 3% to GBX 600/USD 38. Rentokil shares screen as modestly overvalued, trading at a 4% premium to our revised valuation.

Organic sales growth for pest control—Rentokil’s largest category, accounting for 94% of group operating profit following the recent acquisition of Terminix—eased in the second quarter to 5.6%, from an elevated 6.4% in the first three months of 2023. The integration of Terminix into Rentokil’s North American operations is also progressing to plan in 2023. Rentokil realised USD 37 million in cost synergies in the first half of 2023 and remains on track to deliver against its cost synergy target of USD 200 million by the end of 2025.

The hygiene and wellness category also performed strongly in the first half of 2023, delivering revenue growth of 5.2%, excluding one-off pandemic-related disinfection revenue. The performance of the category’s core washroom services was particularly strong, offset partially by a softer organic performance from the premises and enhanced environment division.

We think the darkening economic outlook remains a modest headwind to organic growth throughout the remainder of 2023 and into 2024. Still, our long-term expectations are unchanged with global growth likely to rebound solidly in 2025.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Grant Slade

Senior Equity Analyst
More from Author

Grant Slade is a senior equity analyst, ESG, for Morningstar Holland BV, a wholly owned subsidiary of Morningstar, Inc. Alongside his focus on environmental, social, and governance equity research, Slade also covers U.K. homebuilding stocks.

Prior to his current role, Slade was a senior equity analyst for Morningstar Australasia where he covered building and construction materials, packaging, and other industrials stocks. Before joining Morningstar in 2018, Slade was an equity research analyst with Capital Dynamics, a global fund manager based across the Asia-Pacific region.

Slade holds a Master of Economic Analysis from the University of Sydney, and bachelor's degrees in economics and biotechnology from the Queensland University of Technology. He also holds the Chartered Financial Analyst® designation.

Sponsor Center